165 related articles for article (PubMed ID: 35083132)
1. Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma.
Yin Z; Zhou M; Liao T; Xu J; Fan J; Deng J; Jin Y
Front Oncol; 2021; 11():673567. PubMed ID: 35083132
[TBL] [Abstract][Full Text] [Related]
2. Identification of Immune-Related lncRNA Pairs and Construction and Validation of a New Prognostic Signature of Colon Cancer.
Xu M; Li Q; Zhang J; Xie H
Can J Gastroenterol Hepatol; 2022; 2022():5827544. PubMed ID: 35399646
[TBL] [Abstract][Full Text] [Related]
3. Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature.
Qi X; Chen G; Chen Z; Li J; Chen W; Lin J; Lin L
Int J Gen Med; 2021; 14():4279-4289. PubMed ID: 34421308
[TBL] [Abstract][Full Text] [Related]
4. A novel immune-related lncRNA signature predicts the prognosis and immune landscape in ccRCC.
Dai L; Pan D; Jin J; Lv W
Aging (Albany NY); 2024 Mar; 16(6):5149-5162. PubMed ID: 38484738
[TBL] [Abstract][Full Text] [Related]
5. A novel prognostic signature of immune-related lncRNA pairs in lung adenocarcinoma.
Liu Y; Wu Q; Fan X; Li W; Li X; Zhu H; Zhou Q; Yu J
Sci Rep; 2021 Aug; 11(1):16794. PubMed ID: 34408216
[TBL] [Abstract][Full Text] [Related]
6. Applying immune-related lncRNA pairs to construct a prognostic signature and predict the immune landscape of stomach adenocarcinoma.
Wang Y; Zhang X; Dai X; He D
Expert Rev Anticancer Ther; 2021 Oct; 21(10):1161-1170. PubMed ID: 34319826
[No Abstract] [Full Text] [Related]
7. Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.
Sun JX; Xia QD; Liu CQ; Xu JZ; Xun Y; Lu JL; Hu J; Wang SG
Dis Markers; 2021; 2021():8800358. PubMed ID: 34512816
[TBL] [Abstract][Full Text] [Related]
8. Immune-Related lncRNA Signature for Predicting the Immune Landscape of Head and Neck Squamous Cell Carcinoma.
Yin J; Li X; Lv C; He X; Luo X; Li S; Hu W
Front Mol Biosci; 2021; 8():689224. PubMed ID: 34327215
[No Abstract] [Full Text] [Related]
9. Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma.
Deng M; Lin JB; Zhao RC; Li SH; Lin WP; Zou JW; Wei W; Guo RP
BMC Cancer; 2021 Dec; 21(1):1347. PubMed ID: 34923955
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma.
Wang Y; Xu J; Fang Y; Gu J; Zhao F; Tang Y; Xu R; Zhang B; Wu J; Fang Z; Li Y
Front Immunol; 2022; 13():950001. PubMed ID: 36091041
[TBL] [Abstract][Full Text] [Related]
11. Immune-related lncRNA pairs as novel signature to predict prognosis and immune landscape in melanoma patients.
Li Z; Wei J; Zheng H; Gan X; Song M; Zhang Y; Jin Y
Medicine (Baltimore); 2022 Jan; 101(1):e28531. PubMed ID: 35029920
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Immune-Related Long Non-coding RNAs to Construct a Novel Signature and Predict the Prognosis and Immune Landscape of Soft Tissue Sarcoma.
Lin Z; Pang K; Li H; Zhang X; Wan J; Zheng T; Liu T; Peng W
Front Cell Dev Biol; 2021; 9():709241. PubMed ID: 34631703
[No Abstract] [Full Text] [Related]
13. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
Zhou J; Wang X; Li Z; Jiang R
Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900
[TBL] [Abstract][Full Text] [Related]
14. Cross-talk between necroptosis-related lncRNAs to construct a novel signature and predict the immune landscape of lung adenocarcinoma patients.
Wu J; Song D; Zhao G; Chen S; Ren H; Zhang B
Front Genet; 2022; 13():966896. PubMed ID: 36186456
[No Abstract] [Full Text] [Related]
15. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X
Front Oncol; 2023; 13():1182434. PubMed ID: 37346073
[TBL] [Abstract][Full Text] [Related]
16. Predicting the immune landscape of invasive breast carcinoma based on the novel signature of immune-related lncRNA.
Shen S; Chen X; Hu X; Huo J; Luo L; Zhou X
Cancer Med; 2021 Sep; 10(18):6561-6575. PubMed ID: 34378851
[TBL] [Abstract][Full Text] [Related]
17. A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma.
Chen L; Cai Z; Lyu K; Cai Z; Lei W
Bioengineered; 2021 Dec; 12(1):2311-2325. PubMed ID: 34167440
[TBL] [Abstract][Full Text] [Related]
18. A Novel Signature Constructed by Immune-Related LncRNA Predicts the Immune Landscape of Colorectal Cancer.
Sun M; Zhang T; Wang Y; Huang W; Xia L
Front Genet; 2021; 12():695130. PubMed ID: 34434220
[TBL] [Abstract][Full Text] [Related]
19. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.
Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA
Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203
[TBL] [Abstract][Full Text] [Related]
20. A Novel Prognostic Signature of Immune-Related Long Noncoding RNA Pairs for Tumor-Infiltrating Immune Cells and Drug Susceptibility in Breast Cancer.
Li S; Sun X; Li J; Zheng A; Cao Y; Guo Y; Jin F
DNA Cell Biol; 2022 Feb; 41(2):103-115. PubMed ID: 34762509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
